继发于来伐替尼治疗的肠道肺炎和腹腔积气。

IF 2.7 4区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Revista Espanola De Enfermedades Digestivas Pub Date : 2024-11-19 DOI:10.17235/reed.2024.10908/2024

Rania Benabdallah Sebbagh, David Del Pozo Prieto, Inmaculada Beceiro Pedreño, Celia Trueba Collado, Fernán Manuel Salinas Núñez, Lucía González Sánchez-Ocaña, Amelia Castellano López, Susana Tabernero da Veiga

{"title":"继发于来伐替尼治疗的肠道肺炎和腹腔积气。","authors":"Rania Benabdallah Sebbagh, David Del Pozo Prieto, Inmaculada Beceiro Pedreño, Celia Trueba Collado, Fernán Manuel Salinas Núñez, Lucía González Sánchez-Ocaña, Amelia Castellano López, Susana Tabernero da Veiga","doi":"10.17235/reed.2024.10908/2024","DOIUrl":null,"url":null,"abstract":"Pneumatosis intestinalis is a rare disorder that can be secondary to a variety of causes among which includes oncological treatment. Most cases due to oncological treatment are reported with targeted therapy but there is growing number of cases secondary to tyrosin kinase inhibitors that includes Lenvatinib which it can be used in the treatment of hepatocarcinoma.","PeriodicalId":21342,"journal":{"name":"Revista Espanola De Enfermedades Digestivas","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pneumatosis intestinalis and pneumoperitoneum secondary to treatment with lenvatinib.\",\"authors\":\"Rania Benabdallah Sebbagh, David Del Pozo Prieto, Inmaculada Beceiro Pedreño, Celia Trueba Collado, Fernán Manuel Salinas Núñez, Lucía González Sánchez-Ocaña, Amelia Castellano López, Susana Tabernero da Veiga\",\"doi\":\"10.17235/reed.2024.10908/2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pneumatosis intestinalis is a rare disorder that can be secondary to a variety of causes among which includes oncological treatment. Most cases due to oncological treatment are reported with targeted therapy but there is growing number of cases secondary to tyrosin kinase inhibitors that includes Lenvatinib which it can be used in the treatment of hepatocarcinoma.\",\"PeriodicalId\":21342,\"journal\":{\"name\":\"Revista Espanola De Enfermedades Digestivas\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola De Enfermedades Digestivas\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17235/reed.2024.10908/2024\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola De Enfermedades Digestivas","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17235/reed.2024.10908/2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

肠道肺炎是一种罕见疾病，可继发于多种原因，其中包括肿瘤治疗。大多数肿瘤治疗病例都是通过靶向治疗引起的，但也有越来越多的病例继发于酪氨酸激酶抑制剂，其中包括可用于治疗肝癌的伦伐替尼。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Pneumatosis intestinalis and pneumoperitoneum secondary to treatment with lenvatinib.

Pneumatosis intestinalis is a rare disorder that can be secondary to a variety of causes among which includes oncological treatment. Most cases due to oncological treatment are reported with targeted therapy but there is growing number of cases secondary to tyrosin kinase inhibitors that includes Lenvatinib which it can be used in the treatment of hepatocarcinoma.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Espanola De Enfermedades Digestivas 医学-胃肠肝病学

CiteScore

2.00

自引率

25.00%

发文量

400

审稿时长

6-12 weeks

期刊介绍： La Revista Española de Enfermedades Digestivas, Órgano Oficial de la Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Endoscopia Digestiva (SEED) y Asociación Española de Ecografía Digestiva (AEED), publica artículos originales, editoriales, revisiones, casos clínicos, cartas al director, imágenes en patología digestiva, y otros artículos especiales sobre todos los aspectos relativos a las enfermedades digestivas.